The University of Missouri Board of Curators has awarded Indian-origin professor Raghuraman Kannan the title of Curators’ Distinguished Professor, the university’s top academic honor for teachers and scholars.
Kannan has served as professor of radiology in MU’s School of Medicine since 2005.
Also read: Upstate honors Rajesh Davé with President’s award
He currently serves as the Michael J. and Sharon R. Bukstein Chair in Cancer Research and directs the Cancer Nanotechnology Lab, where research focuses on challenges in cancer treatment, including drug resistance, immune system evasion, and targeted drug delivery.
His team has developed a library of nanoparticle-based delivery vehicles designed to target tumors without damaging healthy tissue. These technologies are being explored for application in ovarian, breast, pancreatic, and liver cancers.
Kannan is a co-founder of four start-up companies at MU. He has already secured million-dollar investments for two of his companies, Nanoparticle Biochem Inc. and Shasun-NBI, LLC. In 2012, Nanoparticle Biochem Inc. was awarded the Tibbetts award for technical innovation and economic development, which was presented at the White House.
Moreover, over 55 of his papers have been published in leading journals, including Advanced Materials and ACS Nano. Seven of his lab’s technologies are patented and have potential clinical applications.
Kannan earned his master’s in chemistry from the Indian Institute of Technology, Madras, in 1993, followed by a PhD in chemistry from the Indian Institute of Science in 1999, where he was awarded a gold medal. His doctoral thesis was awarded the J.C. Ghosh Medal and cash prize for the best PhD thesis at IISc.
Comments
Start the conversation
Become a member of New India Abroad to start commenting.
Sign Up Now
Already have an account? Login